Work

Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications

Year: 2025

Type: review

Source: Current Hematologic Malignancy Reports

DOI: 10.1007/s11899-024-00749-4

Authors: Mifra Faiz, Merle Riedemann, Jonas S. Jutzi, Ann Mullally

Institutions: Brigham and Women's Hospital, Harvard University, VA Palo Alto Health Care System, Stanford Medicine, Stanford University

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Starr Cancer Consortium, U.S. Department of Defense, European Hematology Association, National Institutes of Health, National Heart, Lung, and Blood Institute, Congressionally Directed Medical Research Programs

Awards: Functional and Molecular Dissection of Mutant Calreticulin in Myeloproliferative Neoplasms, Biology and Therapeutic Targeting of Malignant Monocytes in Myeloid Blood Cancers, BIOLOGY AND THERAPEUTIC TARGETING OF MALIGNANT MONOCYTES IN MYELOID BLOOD CANCERS, G5840516970, Elucidating Mechanisms of Therapy-Resistance to Interferon-alfa in Myeloproliferative Neoplasm Stem Cells

OpenAlex ID: W4406133867

FWCI: 1.343

Cites: 59

Cited by: 8

Related to: 10